Normothermic catheter-based intraperitoneal chemotherapy: Systematic review using the IDEAL framework.
메타분석
1/5 보강
Peritoneal metastasis from (PM) remains a significant therapeutic challenge due to poor response to systemic chemotherapy, largely attributable to limited peritoneal drug penetration.
- 연구 설계 systematic review
APA
Leveridge B, Ulucay E, et al. (2026). Normothermic catheter-based intraperitoneal chemotherapy: Systematic review using the IDEAL framework.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 52(3), 111412. https://doi.org/10.1016/j.ejso.2026.111412
MLA
Leveridge B, et al.. "Normothermic catheter-based intraperitoneal chemotherapy: Systematic review using the IDEAL framework.." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 52, no. 3, 2026, pp. 111412.
PMID
41564852 ↗
Abstract 한글 요약
Peritoneal metastasis from (PM) remains a significant therapeutic challenge due to poor response to systemic chemotherapy, largely attributable to limited peritoneal drug penetration. Normothermic catheter-based intraperitoneal chemotherapy (IPC) offers a promising alternative, enabling high local drug concentrations with reduced systemic toxicity. This review applies the IDEAL Framework to assess the evolution of normothermic catheter-based IPC for PM treatment. A systematic review identified 205 original studies and 47 trial protocols or registrations. Normothermic catheter-based IPC has advanced through IDEAL Stages 0 to 3, with preclinical data establishing feasibility, early-phase trials demonstrating safety and efficacy, and recent randomised controlled trials, mainly in Asia, suggesting survival benefit. However, uptake remains limited, and IDEAL Stage 4 data, including long-term follow-up and registry outcomes are lacking. These findings underscore normothermic catheter-based IPC's potential as part of multimodal PM treatment. Further prospective, globally representative trials and long-term data collection are needed to guide broader clinical adoption.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.